| Revision as of 02:44, 16 December 2024 editPrn3117 (talk | contribs)18 editsNo edit summaryTag: Visual edit← Previous edit | Latest revision as of 02:55, 16 December 2024 edit undoJJMC89 bot (talk | contribs)Bots1,161,656 editsm Add {{drafts moved from mainspace}} | ||
| (2 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
| {{db-nocontent|help=off}} | |||
| '''<big>Avoiding Immune Destruction</big>''' | '''<big>Avoiding Immune Destruction</big>''' | ||
| Line 27: | Line 26: | ||
| * The extracellular matrix, cytokines, chemokines, and other cell types that make up the tumor microenvironment can all be modified by cancer cells. | * The extracellular matrix, cytokines, chemokines, and other cell types that make up the tumor microenvironment can all be modified by cancer cells. | ||
| {{Drafts moved from mainspace|date=December 2024}} | |||
Latest revision as of 02:55, 16 December 2024
Avoiding Immune Destruction
Mechanisms
Many strategies exist for cancer cells to evade immune destruction, such as:
1) Immune mimicry
- Myeloid-derived cells are immune cells that stimulate other immune system components, and cancer cells can mimic their actions. As a result, cancer cells are able to avoid the negative effects of inflammation.
2) Hijacking the PD-1/PDL-1 mechanism
- T lymphocytes are rendered inactive by PD-L1, a ligand that binds to PD-1 on their surface and is produced by cancer cells.
3) Modulating immune checkpoints
- To avoid being discovered and eliminated, cancer cells can take use of immunological checkpoints, which are the immune system's natural regulatory systems.
4) Altering the tumor microenvironment
- The extracellular matrix, cytokines, chemokines, and other cell types that make up the tumor microenvironment can all be modified by cancer cells.